Melanoma is a deadly form of skin cancer. Patients who have multiple melanomas or a family history of melanoma may harbor a mutation in the CDKN2A gene, which increases risk for subsequent melanomas. CDKN2A mutations are present in higher frequency in those with 3 or more melanomas.
MRV Research
Seven recent developments involving pediatric dermatology
Recent study findings involving pediatric dermatology included the potential association between moderate-to-severe atopic dermatitis with central obesity and increased blood pressure in children.
Intralesional Treatment Identified As Promising Therapy For Advanced Melanoma
In a recent review article entitled “Intralesional therapy for advanced melanoma: promise and limitation,” Dr. Sanjiv S. Agarwala from St. Luke’s Cancer Center and Temple University in Pennsylvania discusses the need for several lines of therapy in patients with advanced melanoma, and highlights the benefits of intralesional therapy, enumerating the latest treatment options for advanced melanoma patients.
Melanoma’s Addiction to Glutamine Is the Basis for Cancer Growth
Researchers find that melanoma cells are dependent on a source of glutamine for growth irrespective of the mutation(s) that drive the cancer.